CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals

J Biol Chem. 1999 Nov 19;274(47):33545-50. doi: 10.1074/jbc.274.47.33545.

Abstract

X-linked hyper-IgM syndrome is a rare immunodeficiency disorder resulting from mutations in the gene encoding the CD40 ligand (CD154) molecule. These mutations are very heterogeneous, ranging from a single point mutation to a large deletion in the open reading frame. To investigate the molecular mechanisms that are responsible for the functional defect of these mutants, we examined the biochemical properties of 14 hyper-IgM-related CD154 mutant proteins produced by transient expression in COS7 cells. We show that deletion mutants lacking a significant portion of the tumor necrosis factor homologous domain cannot be stably produced. In contrast, point mutants can be detected as oligomers. Surprisingly, gene products of two point mutants, Thr-211 --> Asp and Met-36 --> Arg, can bind to the receptor, CD40. For Thr-211 --> Asp variant, it is comparable to the wild-type protein in its surface expression level, biochemical structure, and functional activities. Thus, it appears that this mutation is a polymorphism of CD154 gene. For Met-36 --> Arg variant, although it is interactive with CD40, it has a much lower surface expression level than wild-type protein. We propose that Met-36 --> Arg mutant represents a prototype of a defective CD154 family whose low cell surface expression of intrinsically active protein is simply insufficient to trigger productive signals through CD40.

MeSH terms

  • Animals
  • Base Sequence
  • Biopolymers
  • CD40 Antigens / immunology*
  • CD40 Ligand
  • COS Cells
  • Cell Line
  • DNA Probes
  • Humans
  • Hypergammaglobulinemia / immunology*
  • Immunoglobulin M / blood*
  • Membrane Glycoproteins / blood*
  • Membrane Glycoproteins / genetics
  • Point Mutation
  • Signal Transduction*

Substances

  • Biopolymers
  • CD40 Antigens
  • DNA Probes
  • Immunoglobulin M
  • Membrane Glycoproteins
  • CD40 Ligand